How Farrell was paid
$16.2M in total for fiscal 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Michael FarrellChief executive officer | $1,272,895 | $9,749,468 | $3,249,907 | $1,738,857 | $190,522 | $16,201,649 |
| Aaron BloomerChief financial officer | $114,550 | $3,300,066 | — | $92,731 | $8,960 | $3,516,307 |
| Justin LeongChief product officer | $752,928 | $3,099,837 | — | $609,510 | $94,846 | $4,557,121 |
| Michael RiderGlobal general counsel and secretary | $535,405 | $1,549,527 | — | $325,066 | $55,015 | $2,465,013 |
| Brett SandercockFormer chief financial officer and special advisor to CEO | $600,164 | $2,599,517 | — | $485,845 | $82,477 | $3,768,003 |
What changed and why
- $16.2M$16,201,649 CEO total compensation exceeded $14,674,543 in fiscal 2025.
- $1.7M$1,738,857 CEO non-equity incentive compensation reflected the performance-based cash incentive plan payout.
- 100%100% of fiscal 2026 performance-based RSUs were earned based on operating profit targets.
- Relative and absolute TSR PSUs use three-year and four-year performance periods, respectively.
- $5.7B$5.7 billion FY26 revenue and more than $1.6 billion of free cash flow supported company performance.
- 199:1 was the fiscal 2026 CEO-to-median-employee pay ratio.
Other Resmed proxy statements
- 2025 proxy statement
Michael Farrell paid $14.7M (+4% on the year), pay ratio 187:1.
Filed Oct 02, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.